Ignite Creation Date:
2025-12-24 @ 5:28 PM
Ignite Modification Date:
2025-12-25 @ 3:02 PM
Study NCT ID:
NCT06958068
Status:
COMPLETED
Last Update Posted:
2025-08-21
First Post:
2025-04-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sexual Health Integration in Treatment of Gynecological Oncology
Sponsor:
Medical University of Silesia
Organization:
Study Overview
Official Title:
Integrating Mandatory Sexual Health Counseling in Gynaecological Oncology: A Paradigm Shift From Diagnosis to Survivorship.
Status:
COMPLETED
Status Verified Date:
2025-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SHIFT-GO
Brief Summary:
The goal of this cross-section observational and questionary based study is to learn how geological cancer survivors perceive sexual health support given by health care professionals during diagnosis and treatment process.
The main question to be answered is:
Who, when and to what extend should discuss the sexual health issues
The participants will answer online survey questions about Sexual health issues and Sexual counselling during diagnosis, treatment and follow-up.
The main question to be answered is:
Who, when and to what extend should discuss the sexual health issues
The participants will answer online survey questions about Sexual health issues and Sexual counselling during diagnosis, treatment and follow-up.
Detailed Description:
The main aim of the study is to verify who, from medical specialist, should discuss the sexual health issues in gynecological cancer survivors, when that discussion should take places and to what exited all sexual issues should be discusses.
The secondary end points are:
* to establish factors affecting returning to sexual activities defined as any type of physical contact with a partner engaging sexual organs as well as mutual and solo masturbation.
* to verified if gender of counselling specialist is important to patients.
The study is a cross-section observation one. It is based on a survey containing questions regarding basic socioeconomical factors, treatment history, reproductive history, and those concerning the opinion who, when, to what extend and how should ask about sexual issues during therapy modalities planning, treatment and follow-up.
Women after completing a treatment irrespectively of its type (surgery, radiation, chemotherapy, immune check point inhibitors) will be eligible for the study. Those who are no more sexually active and currently have no sexual partner will also be included.
After collecting the date three main analysis will be conducted to answer the study questions.
The results will be used as a basic for further work on recommendation on sexual health counselling in gynecological malignancies.
The secondary end points are:
* to establish factors affecting returning to sexual activities defined as any type of physical contact with a partner engaging sexual organs as well as mutual and solo masturbation.
* to verified if gender of counselling specialist is important to patients.
The study is a cross-section observation one. It is based on a survey containing questions regarding basic socioeconomical factors, treatment history, reproductive history, and those concerning the opinion who, when, to what extend and how should ask about sexual issues during therapy modalities planning, treatment and follow-up.
Women after completing a treatment irrespectively of its type (surgery, radiation, chemotherapy, immune check point inhibitors) will be eligible for the study. Those who are no more sexually active and currently have no sexual partner will also be included.
After collecting the date three main analysis will be conducted to answer the study questions.
The results will be used as a basic for further work on recommendation on sexual health counselling in gynecological malignancies.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: